Diastereoselective synthesis of 3-phosphonomethyl-substituted cyclohexyl- and cyclohex-2-enylglycines

Synlett

Volumn , Issue 5, 2003, Pages 689-693

  Ruiz, María ^a   Ojea, Vicente ^a   Conde, Susana ^a   Quintela, José M ^a  

^a UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

1,3 dienylphosphonates; Conjugate addition; Cyclohexylglycines; Phosphono amino acids; Stereoselectivity

Indexed keywords

GLYCINE; GLYCINE DERIVATIVE; LEUCINE; LITHIUM DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHONIC ACID DERIVATIVE;

ARTICLE; CHEMICAL REACTION KINETICS; CHROMATOGRAPHY; DIASTEREOISOMER; ENANTIOMER; ENANTIOSELECTIVITY; ISOMER; STEREOCHEMISTRY; SYNTHESIS;

EID: 0037266873     PISSN: 09365214     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. New address: S. Conde, Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037, USA.
2. CNS Neurotransmitters and Neuromodulators: Glutamate; Stone, T. W., Ed.; CRC: Boca Raton, Florida, 1995.
3. The Ionotropic Glutamate Receptors; Monahan, D. T.; Wenthold, R. J., Eds.; Humana: Totowa, New Jersey, 1997.
4. (a) Hollmann, M.; Heinemann, S. Annu. Rev. Neurosci. 1994, 17, 31.
5. (b) Matsuda, K.; Kamiya, Y.; Matsuda, S.; Yuzaki, M. Mol. Brain Res. 2002, 100, 43.
6. Jane, D. Pharmacology of NMDA receptors, in Glutamate and GABA Receptors and Transporters; Egebjerg, J.; Schousboe, A.; Krogsgaard-Larsen, P., Eds.; Taylor & Francis: London, UK, 2002, 69.
7. Muir, K. W.; Lees, K. R. Stroke 1995, 26, 503.
8. (a) Baudy, R. B.; Fletcher, H. III.; Yardley, J. P.; Zaleska, M. M.; Bramlett, D. R.; Tasse, R. P.; Kowal, D. M.; Katz, A. H.; Moyer, J. A.; Abou-Gharbia, M. J. Med. Chem. 2001, 44, 1516.
9. (b) Swahn, B.-M.; Claesson, A.; Pelcman, B.; Besidski, Y.; Molin, H.; Sandberg, M. P.; Berge, O.-G. Bioorg. Med. Chem. Lett. 1996, 6, 1635.
10. (a) Kidney, W. A.; Abou-Gharbia, M.; Garrison, D. T.; Schmid, J.; Kowal, D. M.; Bramlett, D. R., Miller, T. L.; Zaleska, M. M.; Moyer, J. A. J. Med. Chem. 1998, 41, 236.
11. (b) Childers, W. E. Jr.; Abou-Gharbia, M.; Moyer, J. A.; Zaleska, M. M. Drugs Future 2002, 27, 633.
12. (a) Ruiz, M.; Ojea, V.; Quintela, J. M.; Guillín, J. J. Chem. Commun. 2002, 1600.
13. (b) Fernández, M. C.; Ruiz, M.; Ojea, V.; Quintela, J. M. Tetrahedron Lett. 2002, 43, 5909.
14. (c) Fernández, M. C.; Quintela, J. M.; Ruiz, M.; Ojea, V. Tetrahedron: Asymmetry 2002, 13, 233.
15. (d) Ojea, V.; Ruiz, M.; Shapiro, G.; Pombo-Villar, E. J. Org. Chem. 2000, 65, 1984.
16. (e) Ojea, V.; Conde, S.; Ruiz, M.; Fernández, M. C.; Quintela, J. M. Tetrahedron Lett. 1997, 38, 4311.
17. For the synthesis of D- and L-AP6 based on alkylation of modified Seebach imidazolidinones, see: García-Barradas, O.; Juaristi, E. Tetrahedron: Asymmetry 1997, 8, 1511.
18. Cyclohexylglycines are attractive molecules for the pharmaceutical industry, as they are widely found in natural products and their incorporation into peptide inhibitors renders resistance to peptidases and impart pharmaceutical stability. See: Venkatraman, S.; Njoroge, F. G.; Girijavallabhan, V.; McPhail, A. T. J. Org. Chem. 2002, 67, 2686.
19. For previous Wadsworth-Emmons olefinations of carbonyl compounds with tetraethyl methylenebisphosphonate anions, see: Teulade, M.-P.; Savignac, P.; Aboujaoude, E. E.; Liétge, S.; Collignon, N. J. Orgmet. Chem. 1986, 304, 283.
20. 2 or RP-18), and their spectral data (IR, FABMS and NMR) were consistent with the proposed structures.
21. 4JC2′-P(cis) values range from 6.4-9.2 Hz.
22. Multigram quantities of (2S)-2-tert-butyl-3,6-dietoxy-2,5-dihydropyrazine were obtained from Novartis Kilo Laboratory. When (2S)-2,5-dihydro-3,6-dimetoxy-2-isopropylpyrazine (available from Fluka and Merck) was used for the reaction with 3a,b and 4a,b, analogous yields and selectivities were obtained. The excess of Schöllkopf's reagent could be almost completely recovered, and showed no racemization.
23. Busch, K.; Groth, U. M.; Kühnle, W.; Schöllkopf, U. Tetrahedron 1992, 48, 5607.
24. (a) Schöllkopf, U.; Neubauer, H.-J. Synthesis 1982, 861.
25. (b) Schöllkopf, U. Tetrahedron 1983, 39, 2085.
26. (c) Schöllkopf, U.; Busse, U.; Lonsky, R.; Hinrichs, R. Liebigs Ann. 1986, 12, 2150.
27. (d) Groth, U.; Halfbrodt, W.; Schöllkopf, U. Liebigs Ann. 1992, 4, 351.
28. 2O) δ: 30.45.
29. For previous NBS-mediated lactonizations of 2-amino-4-pentenoic acid derivatives, see: Ohfune, Y.; Hori, K.; Sakaitani, M. Tetrahedron Lett. 1986, 27, 6079.
30. Ojea, V.; Ruiz, M.; Vilar, J.; Quintela, J. M. Tetrahedron: Asymmetry 1996, 7, 3335.
31. 22 as implemented in the Gaussian 98 program package, revision A. 11. Density functional theory treatment was reduced to an inner model constituted by lithiated dihydropyrazinone and butadienylphosphonic acid in the presence of two water molecules. Ethyl groups were replaced by methyl ones in the complete models.
32. Svensson, M.; Humbel, S.; Froese, R. D. J.; Matsubara, T.; Sieber, S.; Morokuma, K. J. Phys. Chem. 1996, 100, 19357.
33. Most stable disolvated TSs located at the ONIOM[B3LYP/6-31G (d):PM3] level of theory for the addition of 2 to (4R)-4b and (4S)-4b are shown in Figure 2.